{
  "nctId": "NCT02319967",
  "briefTitle": "Coordinated Healthcare Interventions for Childhood Asthma Gaps in Outcomes",
  "officialTitle": "Coordinated Healthcare Interventions for Childhood Asthma Gaps in Outcomes (CHICAGO Plan)",
  "protocolDocument": {
    "nctId": "NCT02319967",
    "filename": "Prot_SAP_000.pdf",
    "label": "Study Protocol and Statistical Analysis Plan",
    "date": "2017-12-01",
    "uploadDate": "2018-12-11T10:29",
    "size": 3646024,
    "downloadUrl": "https://clinicaltrials.gov/api/v2/studies/NCT02319967/document/Prot_SAP_000.pdf",
    "hasProtocol": true,
    "hasSap": true,
    "hasIcf": false
  },
  "phase": [
    "NA"
  ],
  "studyType": "INTERVENTIONAL",
  "allocation": "RANDOMIZED",
  "interventionModel": "PARALLEL",
  "masking": "SINGLE",
  "enrollmentInfo": {
    "enrollmentCount": 373,
    "enrollmentType": "ACTUAL"
  },
  "timeline": {
    "startDate": "2015-03",
    "completionDate": "2017-03",
    "primaryCompletionDate": "2017-03",
    "firstSubmitDate": "2014-12-15",
    "firstPostDate": "2014-12-19"
  },
  "eligibilityCriteria": {
    "criteria": "Inclusion criteria (all of the following):\n\n1. Child is 5-11 years of age (a population in whom a diagnosis of asthma is generally reliable, and in whom exacerbations are common);\n2. Child is presenting to the ED, urgent care center, or observation unit at a participating clinical center (Anne and Robert H. Lurie Children's Hospital of Chicago, Sinai Health System's Mount Sinai Hospital, John H. Stroger Jr. Hospital of Cook County Health \\& Hospitals System, Rush University Medical Center, University of Chicago Medicine Comer Children's Hospital, and the University of Illinois Hospital \\& Health Sciences System);\n3. Child is treated with at least 1 dose of an inhaled or nebulized short-acting bronchodilator (quick-relief medication);\n4. Child received systemic corticosteroids in the ED OR the caregiver reported at least 1 additional acute care visit for asthma in the previous 6 months (defined as an asthma-related ED visit or urgent care visit, or course of systemic corticosteroids);\n5. Child and caregiver approached at least 1 hour after receipt of the first dose of quick-relief medication or systemic corticosteroids, whichever occurred first;\n6. Diagnosis of asthma exacerbation by treating clinician;\n7. Treating ED clinician indicates the child is likely to be discharged to home; and\n8. Caregiver reports that English or Spanish is the preferred language at home.\n\nExclusion criteria (none of the following):\n\n1. Caregiver declines to provide informed consent, or the child declines to provide assent;\n2. Child is admitted to an intensive care unit or transferred to another healthcare facility;\n3. Child or another member of the child's primary household is a current or previous participant in the CHICAGO Plan;\n4. Child is enrolled in another study involving a health-related intervention;\n5. A CHW is already visiting the home as part of another program;\n6. Child does not reside in Chicago.",
    "healthyVolunteers": false,
    "sex": "ALL",
    "minimumAge": "5 Years",
    "maximumAge": "11 Years",
    "stdAges": [
      "CHILD"
    ]
  },
  "endpoints": {
    "primary": [
      {
        "measure": "PROMIS Asthma Impact Scale (v1.0, SF8a)",
        "description": "Raw scores (0-32) were converted to T-scores to measure change from index visit to 6-month primary endpoint. Low scores indicate better asthma; high scores indicate worse asthma.\n\nPROMIS Asthma Impact Scale, Pediatric: Min possible T-score: 31.5; Max possible T-score: 76.2 Possible range for change in T-score is \\[-44.7 to 44.7\\]\n\nPROMIS Asthma Impact Scale, Parent proxy: Min possible T-score: 32; Max possible T-score: 80 Possible range for change in T-score is \\[-48 to 48\\]\n\nThe reported value represents a change in T-score from baseline to 6 months after index ED discharge.\n\nA negative change in score indicates improvement in asthma. A positive change in score indicates worsening of asthma. A score of 0 indicates no change.",
        "timeFrame": "Baseline and 6 months after index ED discharge"
      },
      {
        "measure": "PROMIS Satisfaction With Participation in Social Roles (v1.0, SF4a)",
        "description": "Raw scores (4-20) were converted to T-scores to measure change from index visit to 6-month primary endpoint. Low scores indicate less satisfaction among caregivers; high scores indicate more satisfaction among caregivers.\n\nPROMIS Satisfaction With Participation in Social Roles: Min possible T-score: 29.0; Max possible T-score: 64.1 Possible range for change in T-score is \\[-35.1 to 35.1\\]\n\nThe reported value represents a change in T-score from baseline to 6 months after index ED discharge.\n\nA negative change in score indicates less satisfaction among caregivers. A positive change in score indicates a more satisfaction among caregivers. A score of 0 indicates no change.",
        "timeFrame": "Baseline and 6 months after index ED discharge"
      }
    ],
    "secondary": [
      {
        "measure": "Childhood Asthma Control Test (cACT)",
        "description": "The scores of each item were summed for a total score (0-27) to measure change from index to 6-month primary endpoint. Low scores indicate worse asthma; high scores indicate better asthma.\n\nChildhood Asthma Control Test (cACT): Min possible score: 0; Max possible score: 27 Possible range for change in score is \\[-27 to 27\\]\n\nThe reported value represents a change in score from baseline to 6 months after index ED discharge.\n\nA negative change in score indicates improvement in asthma. A positive change in score indicates worsening of asthma. A score of 0 indicates no change.",
        "timeFrame": "Baseline and 6 months after index ED discharge"
      },
      {
        "measure": "PROMIS Anxiety (v1.0, SF4a)",
        "description": "Raw scores (4-20) were converted to T-scores to measure change from index visit to 6-month primary endpoint. Low scores indicate less anxiety; high scores indicate more anxiety.\n\nPROMIS Anxiety: Min possible T-score: 40.3; Max possible T-score: 81.6 Possible range for change in T-score is \\[-41.3 to 41.3\\]\n\nThe reported value represents a change in T-score from baseline to 6 months after index ED discharge.\n\nA negative change in score indicates improvement in anxiety. A positive change in score indicates worsening of anxiety. A score of 0 indicates no change.",
        "timeFrame": "Baseline and 6 months after index ED discharge"
      },
      {
        "measure": "PROMIS Depression (v1.0, SF4a)",
        "description": "Raw scores (4-20) were converted to T-scores to measure change from index visit to 6-month primary endpoint. Low scores indicate less depression; high scores indicate more depression.\n\nPROMIS Depression: Min possible T-score: 41.0; Max possible T-score: 79.4 Possible range for change in T-score is \\[-38.4 to 38.4\\]\n\nThe reported value represents a change in T-score from baseline to 6 months after index ED discharge.\n\nA negative change in score indicates improvement in depression. A positive change in score indicates worsening of depression. A score of 0 indicates no change.",
        "timeFrame": "Baseline and 6 months after index ED discharge"
      },
      {
        "measure": "PROMIS Fatigue (v1.0, SF4a)",
        "description": "Raw scores (4-20) were converted to T-scores to measure change from index visit to 6-month primary endpoint. Low scores indicate less fatigue; high scores indicate more fatigue.\n\nPROMIS Fatigue: Min possible T-score: 33.7; Max possible T-score: 75.8 Possible range for change in T-score is \\[-42.1 to 42.1\\]\n\nThe reported value represents a change in T-score from baseline to 6 months after index ED discharge.\n\nA negative change in score indicates improvement in fatigue (i.e., less fatigue). A positive change in score indicates worsening of fatigue (i.e., more fatigue). A score of 0 indicates no change.",
        "timeFrame": "Baseline and 6 months after index ED discharge"
      },
      {
        "measure": "PROMIS Sleep Disturbance (v1.0, SF4a)",
        "description": "Raw scores (4-20) were converted to T-scores to measure change from index visit to 6-month primary endpoint. Low scores indicate less sleep disturbance; high scores indicate more sleep disturbance.\n\nPROMIS Sleep Disturbance (v1.0, SF4a): Min possible T-score: 32.0; Max possible T-score: 73.3 Possible range for change in T-score is \\[-41.3 to 41.3\\]\n\nThe reported value represents a change in T-score from baseline to 6 months after index ED discharge.\n\nA negative change in score indicates improvement in sleep disturbance (i.e., less sleep disturbance). A positive change in score indicates worsening of sleep disturbance (i.e., more sleep disturbance). A score of 0 indicates no change.",
        "timeFrame": "Baseline and 6 months after index ED discharge"
      },
      {
        "measure": "Pediatric Asthma Caregiver's Quality of Life Questionnaire (PACQLQ)",
        "description": "The overall score is the mean score across all 13 items. Each item is scored on a 7-point Likert scale with 1 indicating severe impairment and 7 indicating no impairment. Higher scores indicate better quality of life; lower scores indicate worse quality of life.\n\nPediatric Asthma Caregiver's Quality of Life Questionnaire (PACQLQ): Min possible score: 1; Max possible score: 7 Possible range for change in score is \\[-6 to 6\\]\n\nThe reported value represents a change in overall score from baseline to 6 months after index ED discharge.\n\nA negative change in score indicates worsening quality of life. A positive change in score indicates improvement in quality of life. A score of 0 indicates no change.",
        "timeFrame": "Baseline and 6 months after index ED discharge"
      },
      {
        "measure": "Number of Participants With All-cause Emergency Department (ED) or Urgent Care Visits",
        "description": "Count of participants (children) with at least one all-cause ED or urgent care visit at 6 months",
        "timeFrame": "6 months post index ED discharge"
      },
      {
        "measure": "Number of Participants With All-cause Hospitalizations",
        "description": "Count of participants (children) with at least one all-cause hospitalization at 6 months",
        "timeFrame": "6 months post index ED discharge"
      },
      {
        "measure": "Self-management Practices After ED Discharge: Number of Participants Who Filled Prescriptions for Systemic Corticosteroids",
        "description": "Count of participants who filled a prescription for systemic corticosteroids within 7 days of discharge",
        "timeFrame": "7 days post index ED discharge"
      },
      {
        "measure": "Self-management Practices After ED Discharge: Number of Participants Who Filled Prescriptions for Inhaled Corticosteroids or Other Controller",
        "description": "Count of participants who filled prescription for inhaled corticosteroids or other controller within 7 days of discharge",
        "timeFrame": "7 days post index ED discharge"
      },
      {
        "measure": "Self-management Practices After ED Discharge: Number of Participants Who Attended an Outpatient Appointment With Patient-identified Asthma Provider",
        "description": "Count of participants who attended follow-up appointment with patient-identifier asthma provider within 4 weeks of discharge",
        "timeFrame": "4 weeks post index ED discharge"
      },
      {
        "measure": "Indicator of Guideline-consistent Care Provided on ED Discharge: Number of Participants Who Received Instructions to Use Systemic Corticosteroids",
        "description": "Count of participants who were provided documented discharge instructions to use systemic corticosteroids",
        "timeFrame": "At index ED discharge"
      },
      {
        "measure": "Indicator of Guideline-consistent Care Provided on ED Discharge: Number of Participants Who Received Instructions to Use Inhaled Corticosteroids or Other Controller",
        "description": "Count of participants who were provided documented discharge instructions to use inhaled corticosteroids or other controller",
        "timeFrame": "At index ED discharge"
      },
      {
        "measure": "Indicator of Guideline-consistent Care Provided on ED Discharge: Number of Participants Who Received Instructions to Use Inhaled Rescue Medication",
        "description": "Count of participants who were provided documented discharge instructions to use an inhaled rescue medication",
        "timeFrame": "At index ED discharge"
      },
      {
        "measure": "Indicator of Guideline-consistent Care Provided on ED Discharge: Number of Participants Who Received a Follow-up Appointment Scheduled by ED Staff",
        "description": "Count of participants who were provided documented discharge instructions for a follow-up appointment scheduled within 4 weeks of discharge",
        "timeFrame": "At index ED discharge"
      }
    ],
    "other": []
  },
  "complexityMetrics": {
    "eligibilityCriteria": {
      "inclusionCount": 1,
      "exclusionCount": 1,
      "totalCount": 2
    },
    "endpoints": {
      "primaryCount": 2,
      "secondaryCount": 15,
      "otherCount": 0,
      "totalCount": 17
    },
    "studyDesign": {
      "phases": [
        "NA"
      ],
      "isRandomized": true,
      "isMasked": true,
      "interventionModel": "PARALLEL"
    },
    "overallComplexityScore": 100,
    "complexityCategory": "Highly Complex"
  },
  "collectionDate": "2025-09-22T02:29:22.043Z",
  "dataSource": "ClinicalTrials.gov API v2 - Comprehensive Collection"
}